The first Neuralink product will be called “Telepathy,” according to Musk, allowing users to control digital devices using only their thoughts.
The first human patient implanted with Neuralink’s brain-computer device is “recovering well,” according to Neuralink owner Elon Musk.
In a Jan. 29 post to X, Musk said the person successfully received the implant on Sunday, Jan. 28. He added that the initial results showed “promising neuron spike detection.”
Neuralink first opened up applications for human clinical trials in September last year, after the company had received approval for its PRIME (Precise Robotically Implanted Brain-Computer Interface) study from the United States Food and Drug Administration in May 2023, according to a Sept. 19 blog post from the firm.
